Growth hormone for children with chronic kidney disease

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 3, 2011, Pages

  Hodson, Elisabeth M ^a,b   Willis, Narelle S ^a,b   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE; LIPID; PLACEBO;

ACUTE GRAFT REJECTION; ASTHMA; BODY HEIGHT; BONE AGE; BRAIN PSEUDOTUMOR; CHILD; CHRONIC KIDNEY DISEASE; CLAUDICATION; COCHRANE LIBRARY; CONSERVATIVE TREATMENT; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; EMBASE; EVIDENCE BASED PRACTICE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GRANULOMA; GROWTH RETARDATION; HEADACHE; HODGKIN DISEASE; HORMONAL THERAPY; HUMAN; HYPERTENSION; IDIOPATHIC SCOLIOSIS; INFECTION; INJECTION PAIN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LYMPHADENOPATHY; MEDLINE; PAPILLEDEMA; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; TREATMENT RESPONSE; VALGUS KNEE; WHEEZING;

EID: 84979710844     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003264.pub3     Document Type: Review

References (62)

1. Broyer M. Results and side-effects of treating children with growth hormone after kidney transplantation - a preliminary report. Pharmacia & Upjohn Study Group. Acta Paediatrica Supplement 1996;417:76-9.
2. Broyer M, Guest G, Crosnier H, Berard E, on behalf of the French Society for Pediatric Nephrology. A multicentric open randomized controlled study of rhGH therapy in short children after kidney transplantation [abstract]. Journal of the American Society of Nephrology 1995;6(3):1075.
3. Broyer M, on behalf of the study group. A multi-centre open, randomized, controlled study evaluating the effect of growth hormone therapy in short children after renal transplantation [abstract]. Pediatric Nephrology 1995;9(6): C49.
4. Guest G, Berard E, Crosnier H, Chevallier T, Rappaport R, Broyer M. Effects of growth hormone in short children after renal transplantation. Pediatric Nephrology 1998;12 (6):437-46.
5. Callis LL, del Valle CJ, Garcia L, Garcia Nieto V, Gonzalez Diaz JP, Heras M, et al.Randomized open multicentre study to assess treatment with recombinant human growth hormone in children with low height and chronic renal insufficiency [abstract]. Anales Espanoles de Pediatria 1996; 45(3):328.
6. Fine RN, Attie KM, Kuntze J, Brown DF, Kohaut EC. Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Genentech Collaborative Study Group. Pediatric Nephrology 1995;9: 451-7.
7. Fine RN, Kohaut EC, Brown D, Perlman AJ. Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. Journal of Pediatrics 1994;124(3):374-82.
8. Fine RN, Stablein D, Cohen AH, Tejani A, Kohaut E. Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS. Kidney International 2002;62(2): 688-96.
9. Hertel NT, Holmberg C, Rönnholm KAR, Jacobsen BB, Ølgaard, Meeuwisse GW, et al.Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal failure--a report on linear growth and adverse effects. Journal of Pediatric Endocrinology 2002;15 (5):577-88.
10. de Graaff LC, Mulder PG, Hokken-Koelega AC. Body proportions before and during growth hormone therapy in children with chronic renal failure. Pediatric Nephrology 2003;18(7):679-84.
11. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Pediatric Nephrology 2000;14 (7):701-6.
12. Hokken-Koelega AC, Stijnen T, de Muinck Keizer- Schrama SM, Wit JM, Wolff ED, de Jong MC, et al.Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Lancet 1991;338(8767):585-90.
13. Hokken-Koelega AC, Stijnen T, de Jong MC, Donckerwolcke RA, de Muinck Keizer-Schrama SM, Blum WF, et al.Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. Journal of Clinical Endocrinology & Metabolism 1994;79(4):1185-90.
14. Hokken-Koelega AC, Stijnen T, de Ridder MA, de Muinck Keizer-Schrama SM, Wolff ED, de Jong MC, et al.Growth hormone treatment in growth-retarded adolescents after renal transplant. Lancet 1994;343(8909): 1313-7.
15. Hokken-Koelega AC, Sitjnen T, de Jong RC, Donckerwolcke RA, Groothoff JW, Wolff ED, et al.A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant. Kidney International - Supplement 1996;53:128-34.
16. Ito K, Kawaguchi H and Multicenter Study Group of GH in Japan. A wide applicability of growth hormone (Genotrophin) to growth impairment in children suffering from various renal diseases [abstract]. Pediatric Nephrology 1995;9(6):C70.
17. Kawaguchi H, Ito K. rhGH use in children with CRI and undergoing dialysis post-transplant in Japan: A multicentre study. British Journal of Clinical Practice Supplement 1996; 85(Supplement 1):26-31.
18. Ito K, Kawaguchi H. The use of recombinant human GH (rhGH) in growth failure in children with various renal diseases. Clinical Pediatric Endocrinology 1997;6 Suppl(9): 49-53. [EMBASE: 1998192189]
19. Ito K, Kawaguchi Hand JapaneseMulticenter Study Group. A dose modifying effects of growth hormone (GH:NN-798, Norditrophin) in children with chronic renal insufficiency (CRI) [abstract]. Pediatric Nephrology 1995;9(6):C71.
20. Kitagawa T, Ito K, Ito H, Sakai T, Wada H, Kajiwara N. GH treatment of children with chronic renal insufficiency: A Japanese clinical trial. Clinical Pediatric Endocrinology 1997;6 Suppl(10):73-80.
21. Kuizon BD, Goodman WG, Gales B, Juppner H, Salusky IB. Effects of growth hormone on bone and mineral metabolism in dialyzed children [abstract]. Journal of the American Society of Nephrology 1998;9(Program & Abstracts):546-7.
22. Kuizon BD, Goodman WG, Gales B, Sahney S, Juppner H, Salusky IB. Growth hormone therapy inhibits the suppressive effects of calcitriol on bone in patients with secondary hyperparathyroidism [abstract]. Pediatric Nephrology 2001;16:C48.
23. Maxwell H, Rees L. Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology. Archives of Disease in Childhood 1998;79(6):481-7.
24. Brewer ED, Ou C, Hogg RJ. Glomerular filtration rate (GFR) in children with advanced chronic renal failure (CRF) during short term therapy with growth hormone (rhGH)-- a multicenter trial of the southwest pediatric nephrology study group (SPNSG) [abstract]. Journal of the American Society of Nephrology 1994;5(3):326.
25. Powell DR, Attie K, Hintz RL, Liu F, Baker B, Kuntze J, et al.Growth hormone stimulates growth and alters the serum insulin-growth factor axis of children with chronic renal failure: Report of the Southwest Pediatric Nephrology Study Group [abstract]. Pediatric Nephrology 1995;9(6): C70.
26. Powell DR, Durham SK, Brewer ED, Frane JW, Watkins SL,Hogg RJ, et al.Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor binding protein-4 (IGFBP-4) and IGFBP-5 in children: a report of the Southwest Pediatric Nephrology Study Group. Journal of Clinical Endocrinology & Metabolism 1999;84(2): 596-601.
27. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, et al.Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney International 1997;51(6):1970-9.
28. Watkins SL, Hogg RJ, Brewer ED, Powell DR, Boechat I, Brown D, et al.Bone mineral parameters in children with chronic renal fialure (CRF) receiving recombinant human growth hormone (GH). A report of the Southwest Pediatric Nephrology Group. [abstract]. Pediatric Nephrology 1995;9 (6):C51.
29. Sanchez CP, Goodman WG, Kuison BD, Gales B, Malekzadeh M, Saluusky IB. Growth hormone and bone: A randomised prospective study. 16th Annual Meeting. American Society of Transplant Physicians; 1997 May 10- 14; Chicago (USA). 1997:156.
30. Sanchez CP, Goodman WG, Kuizon BD, Ettenger RB, Salusky IB. Growth response to growth hormone therapy varies with bone histology in pediatric renal transplant recipients [abstract]. Journal of the American Society of Nephrology 1998;9(Progams & Abstracts):550.
31. Sanchez CP, Kuizon BD, Goodman WG, Gales B, Ettenger RB, Inez Boechat M, et al.Growth hormone and the skeleton in pediatric renal allograft recipients. Pediatric Nephrology 2002;17(5):322-8.
32. Sanchez CP, Salem M, Ettenger RB. Changes in cyclosporine A levels in pediatric renal allograft recipients receiving recombinant human growth hormone therapy. Transplantation Proceedings 2000;32(8):2807-10.
33. Moreno L, Santos F, Neto A, Ariceta G, Vara J, Alonso A, et al.Improvement in growth after one year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: results of a multi-center, controlled, randomized, open clinical trial [abstract]. Pediatric Nephrology 2010;25:790.
34. Santos F,MorenoML, Neto A, Ariceta G, Vara J, Alonso A, et al.Improvement in growth after 1 year of growth hormone therapy in well-nourished infants with growth retardation secondary to chronic renal failure: Results of a multicenter, controlled, randomized, open clinical trial. Clinical Journal of the American Society of Nephrology 2010;5 (7):1190-7.
35. Ghio L, Damiani B, Garavaglia R, Oppizzi G, Taioli E, Edefonti A. Lipid profile during rhGH therapy in pediatric renal transplant patients. Pediatric Transplantation 2002;6 (2):127-31.
36. Jedrzejowski A, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Lis D, Galazka B, Dyras P. Growth hormone therapy and lipid profile in children on chronic peritoneal dialysis. Pediatric Nephrology 2002;17(10):830-6.
37. Laine J, Krogerus L, Sipila I, Ronnholm K, Holmberg C. Effects of recombinant human growth hormone treatment of renal allograft function and histopathology [abstract]. Pediatric Nephrology 1995;9(6):49.
38. Berard E, Andre JL, Guest G, Berthier F, Afanetti M, Cochat P, et al.Long-term results of rhGH treatment in children with renal failure: experience of the French Society of Pediatric Nephrology. Pediatric Nephrology 2008;23(11): 2031-8.
39. Clayton PE, Cowell CT. Safety issues in children and adolescents during Growth Hormone Therapy - a review. Growth Hormone & IgF Research 2000;10(6):306-17.
40. Cowell CT, Dietsch S. Adverse events during growth hormone therapy. Journal of Pediatric Endocrinology & Metabolism 1995;8(4):243-52.
41. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. In: Chalmers I, Altman DG editor(s). Systematic Reviews. London: BMJ Publishing Group, 1995:17-36.
42. Disney APS, Russ GR, Walker R, Sheil AGR, Collins J, Herbert K, Kerr P. ANZDATA Registry Report 1999. Adelaide: Australia and New Zealand Dialysis and Transplant Registry, 1999.
43. Fine RN. Recombinant human growth hormone (rhGH) in dialysis patient: update 1995. Advances in Peritoneal Dialysis 1995;11:261-5.
44. Fine RN, Stablein D. Long-term use of recombinant human growth hormone in pediatric allograft recipients: a report of the NAPRTCS Transplant Registry. Pediatric Nephrology 2005;20(3):404-8.
45. Fine RN, Martz K, Stablein D. What have 20 years of data from the North American Pediatric Renal Transplant Cooperative Study taught us about growth following renal transplantation in infants, children and adolescents with end-stage renal disease?. Pediatric Nephrology 2010;25(4): 739-46.
46. Haffner D, Schaefer F, Nissel R, Wuhl E, Tönshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. New England Journal of Medicine 2000;343(13):923-30.
47. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
48. National Kidney Foundation. K/DOQI Workgroup. K/ DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. American Journal of Kidney Diseases 2002;39(2 Suppl 1): 1-266.
49. Lefebvre D, McDonald S. Development of a sensitive search strategy for reports of randomised controlled trials in Embase. Fourth International Cochrane Colloquium; 1996 Oct 20-24; Adelaide (Australia). 1996:20-4.
50. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-613.
51. Pettiti DB. Meta-analysis decision analysis and costeffectiveness analysis: methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.
52. Postlethwaite RJ, Eminson DM, Reynolds JM, Wood AJ, Hollis S. Growth in renal failure: a longitudinal study of emotional and behavioural changes during trials of growth hormone treatment. Archives of Disease in Childhood 1998; 78(3):222-9.
53. Reeves GD, Doyle DA. Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship?. Journal of Pediatric Endocrinology 2002;15 Suppl 2:723-30.
54. Reynolds JM, Wood AJ, Eminson DM, Postlethwaite RJ. Short stature and chronic renal failure: what concerns children and parents. Archives of Disease in Childhood 1995; 73(1):36-42.
55. Rizzoni G, Broyer M, Brunner FP, Brynger H, Challah S, Kramer P, et al.Combined report on regular dialysis and transplantation of children in Europe, XIII, 1983. Proceedings of the European Dialysis & Transplant Association - European Renal Association. 1985; Vol. 21: 66-95.
56. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
57. Tönshoff B, Mehls O. Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. Journal of Nephrology 1995; 8(3):133-42. [EMBASE: 1995200628]
58. Wilton P. Adverse events during GH treatment: 10 years' experience in KIGS, a pharmacoepidemiological survey. In: Ranke MB, Wilton P editor(s). Progress in growth hormone therapy - 10 years of KIGS. Mannheim: Ja Barh Verlag, 1999:349-64.
59. Wühl E, Haffner N, Nissel R, Schaefer F, Mehls O and German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Short dialyzed children respond less to growth hormone than patients prior to dialysis. Pediatric Nephrology 1996;10(3):294-8.
60. Vimalachandra D, Craig JC, Cowell C, Knight JF. Growth hormone treatment in children with chronic renal failure: a meta-analysis of randomized controlled trials. Journal of Pediatrics 2001;139(4):560-6.
61. Vimalachandra D, Craig JC, Cowell C, Knight JF. Growth hormone for children with chronic renal failure. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD003264]
62. Vimalachandra D, Hodson EM, Willis NS, Craig JC, Cowell CT, Knight JF. Growth hormone for children with chronic kidney disease. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/ 14651858.CD003264.pub2]